GSK PLC 08 May 2024 GSK plc Results of 24th Annual General Meeting GSK plc ('GSK') held a hybrid Annual General Meeting ('AGM') at 2.30pm...
GSK PLC 08 May 2024 GSK plc Board Committee Change GSK plc today announces the following changes to its Board Committee membership: ...
Strategic collaboration with GSK expanded to accelerate clinical development of alpibectir for the treatment of...
GSK PLC 03 May 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name...
GSK PLC 01 May 2024 GSK plc Total Voting Rights and Capital In conformity with the Financial Conduct Authority's Disclosure Guidance and...
GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance ...
GSK PLC 01 May 2024 GSK makes a strong start to 2024 with improving outlook for the year Broad-based performance drives sales, profits and...
GSK PLC on Wednesday said that the US Food & Drug Administration has accepted a supplemental biologics licence applic ...
GSK PLC 24 April 2024 Issued: 24 April 2024, London UK US FDA accepts for priority review GSK's application for an expanded indication of...
GSK PLC 19 April 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name...
GSK PLC 17 April 2024 GSK plc (the 'Company') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name...
GSK PLC on Wednesday reported new test data for its shingles vaccine and for a potential new oral treatment for a for ...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.